Business Description
Synbio Tech Inc
ISIN : TW0001295004
Total Employee Number:
349Description
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.27 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 1.04 | |||||
Debt-to-EBITDA | 4.71 | |||||
Interest Coverage | 15.62 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 1.42 | |||||
Beneish M-Score | -1.87 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.9 | |||||
3-Year EBITDA Growth Rate | 11.5 | |||||
3-Year EPS without NRI Growth Rate | 21.4 | |||||
3-Year FCF Growth Rate | -152 | |||||
3-Year Book Growth Rate | 10.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.73 | |||||
9-Day RSI | 43.24 | |||||
14-Day RSI | 44.87 | |||||
3-1 Month Momentum % | -14.84 | |||||
6-1 Month Momentum % | -40.31 | |||||
12-1 Month Momentum % | -58.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.2 | |||||
Quick Ratio | 0.83 | |||||
Cash Ratio | 0.59 | |||||
Days Inventory | 164.04 | |||||
Days Sales Outstanding | 36.68 | |||||
Days Payable | 32.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.93 | |||||
Dividend Payout Ratio | 0.66 | |||||
Forward Dividend Yield % | 5.93 | |||||
5-Year Yield-on-Cost % | 5.91 | |||||
3-Year Average Share Buyback Ratio | -3.2 | |||||
Shareholder Yield % | -22.03 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 53.45 | |||||
Operating Margin % | 19.1 | |||||
Net Margin % | 16.94 | |||||
EBITDA Margin % | 28.33 | |||||
FCF Margin % | -54.08 | |||||
OCF Margin % | 13.8 | |||||
ROE % | 14.85 | |||||
ROA % | 6.49 | |||||
ROIC % | 7.83 | |||||
3-Year ROIIC % | 5.95 | |||||
ROC (Joel Greenblatt) % | 11.24 | |||||
ROCE % | 9.91 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 9.18 | |||||
Forward PE Ratio | 23.18 | |||||
PE Ratio without NRI | 9.17 | |||||
Price-to-Owner-Earnings | 15.5 | |||||
PEG Ratio | 2.29 | |||||
PS Ratio | 1.56 | |||||
PB Ratio | 1.25 | |||||
Price-to-Tangible-Book | 1.28 | |||||
Price-to-Operating-Cash-Flow | 11.44 | |||||
EV-to-EBIT | 12.5 | |||||
EV-to-EBITDA | 9.13 | |||||
EV-to-Revenue | 2.59 | |||||
EV-to-FCF | -4.84 | |||||
Price-to-Graham-Number | 0.72 | |||||
Earnings Yield (Greenblatt) % | 8 | |||||
FCF Yield % | -33.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Synbio Tech Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,038.668 | ||
| EPS (TTM) (NT$) | 5.283 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 35.44 | ||
| 14-Day RSI | 44.87 | ||
| 14-Day ATR (NT$) | 1.608131 | ||
| 20-Day SMA (NT$) | 48.903958 | ||
| 12-1 Month Momentum % | -58.61 | ||
| 52-Week Range (NT$) | 46.411883 - 157.032689 | ||
| Shares Outstanding (Mil) | 34.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Synbio Tech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Synbio Tech Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 2.991099 Cash Dividend | 2026-03-27 | 68.80 (-1.43%) | ||
| TWD 3.489615 Cash Dividend | 2025-03-27 | 74.28 (+0.68%) | ||
| 1.02:1 Stock Split | 2024-08-06 | 68.42 (-0.85%) |
Show
Entries
Synbio Tech Inc Frequently Asked Questions
What is Synbio Tech Inc(ROCO:1295)'s stock price today?
The current price of ROCO:1295 is NT$48.50. The 52 week high of ROCO:1295 is NT$157.03 and 52 week low is NT$46.41.
When is next earnings date of Synbio Tech Inc(ROCO:1295)?
The next earnings date of Synbio Tech Inc(ROCO:1295) is .
Does Synbio Tech Inc(ROCO:1295) pay dividends? If so, how much?
The Dividend Yield %  of Synbio Tech Inc(ROCO:1295) is 5.93% (As of Today), Highest Dividend Payout Ratio of Synbio Tech Inc(ROCO:1295) was 0.66. The lowest was 0.27. And the median was 0.47. The  Forward Dividend Yield % of Synbio Tech Inc(ROCO:1295) is 5.93%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Synbio Tech Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers